Q2 AND HALF YEAR RESULTS 2023

Amsterdam, 23 August 2023

AGENDA

  1. Business review
  2. Strategic and operational update
  3. Outlook
  4. Q&A

2

CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS

Certain statements contained in this presentation constitute forward-looking statements. These statements may include, without limitation, statements concerning future results of operations, the Company's share of new and existing markets, general industry and macro-economic trends and the Company's performance relative thereto and statements preceded by, followed by or including the words "believes", "expects", "anticipates", "will", "may", "could", "should", "intends", "estimate", "plan", "goal", "target", "aim" or similar expressions. These forward-looking statements rely on a number of assumptions concerning future events and are subject to uncertainties and other factors, many of which are outside the Company's control that could cause actual results to differ materially from such statements.

3

1. Business review

4

KEY FIGURES

Q2 and HY1 2023

Q2 2023

Q2 2022

delta

Revenue

136.9

126.9

8%

Normalized EBITDA ¹

14.0

13.7

2%

Normalized EBITA ¹

8.2

7.9

4%

Normalized profit before amortization ¹

4.4

5.3

-17%

Net profit

3.7

3.7

0%

Normalized EBITDA as a % of revenue

10.2%

10.8%

HY1 2023

HY1 2022

delta

Revenue

273.7

256.8

7%

Normalized EBITDA ¹

29.7

30.5

-3%

Normalized EBITA ¹

18.1

19.3

-6%

Normalized profit before amortization ¹

10.0

12.9

-22%

Net profit

8.6

8.8

-2%

Normalized EBITDA as a % of revenue

10.9%

11.9%

Normalized EBITA as a % of revenue

6.6%

7.5%

Return on invested capital ¹

14.1%

14.7%

Free cash flow

-12.5

-7.6

Net debt

160.9

145.6

  1. Non-IFRSmeasures adjusted for items generated outside the normal course of business. Invested capital excludes goodwill and intangibles arising from acquisitions.
  • Q2 revenue increased 9% at constant rates of exchange
  • Sales price increases contributed with 6% to Q2 revenue
  • Inflationary margin dilution and sales mix effects put pressure on added value margin
  • 2% increase in normalized EBITDA in Q2 with slight increase in added value and slightly lower operating costs
  • EUR 0.1 million net operating costs normalized from the Q2 results
  • Increased Euribor rates and unfavorable currency results drove EUR 2.2 million higher interest expenses in Q2
  • EUR 5.8 million negative free cash flow in Q2, including EUR 2.5 million payments related to tax audit settlement and restructuring costs
  • Net debt increase of EUR 13.1 million, mainly due to cash portion of the dividend and free cash flow
  • Leverage ratio of 2.8 per 30 June 2023, up from 2.6 at the end of Q1

5

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Kendrion NV published this content on 23 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 August 2023 11:38:06 UTC.